Biotech · Private company · Newton, MA, US
Aquinnah Pharmaceuticals, Inc.
Track this companyFree. Adds Aquinnah Pharmaceuticals, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards5
- Development of a novel Alzheimer's disease therapeutic targeting tauFiscal year 2026 · $997.9KNIH RePORTER 5R44AG060843-06 · fetched Nov 12, 2026
- Development of a novel oral brain penetrant therapeutic for ALS diseaseFiscal year 2026 · $1.5MNIH RePORTER 5R44NS141531-02 · fetched Nov 12, 2026
- Development of a novel oral brain penetrant therapeutic for ALS diseaseFiscal year 2025 · $1.5MNIH RePORTER 1R44NS141531-01A1 · fetched Nov 12, 2026
- Development of a novel Alzheimer's disease therapeutic targeting tauFiscal year 2025 · $998.7KNIH RePORTER 5R44AG060843-05 · fetched Nov 12, 2026
- Development of a novel Alzheimer's disease therapeutic targeting tauFiscal year 2024 · $999.7KNIH RePORTER 2R44AG060843-04 · fetched Nov 12, 2026